Discover 1,859 paid clinical trials in Virginia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Virginia provides numerous opportunities for both healthy volunteers and people with specific medical conditions to participate in paid medical research. Major research centers in Richmond, Virginia Beach, and Norfolk are actively seeking participants, offering access to innovative treatments and advanced care.
Filter
1
Filter results
Results: 1,859
Active & Responsive
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Location: Boston MA, New York NY, Philadelphia PA, Richmond VA,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT06911632
Recruiting
Active & Responsive
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
for
Urinary Incontinence,Stress
Location: Levis, Quebec, Philadelphia PA, Virginia Beach VA,
Sponsor: Eli Lilly and Company
Sex: Female
Age: 18+
Code: NCT07202884
Phase3, Recruiting
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for
Cardiovascular Disease
Location: Boston MA, East Greenwich RI, Hamden CT, Sherbrooke,
Sponsor: Amgen
Sex: All
Age: 50 - 70+
Code: NCT07136012
Phase3, Recruiting
Active & Responsive
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Boston MA, New Haven CT, New York NY, New Brunswick NJ,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05216432
Phase1, Recruiting
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Providence RI, New York NY, Newark NJ,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase2, Phase3, Recruiting
Active & Responsive
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
for
Treatment Resistant Depression
Location: Boston MA, Nashua NH, New York NY, Woodbury NY,
Sponsor: LivaNova
Sex: All
Age: 18+
Code: NCT03887715
Recruiting
Active & ResponsiveNew
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
for
Overweight, Obesity
Location: Newport News VA, Wilmington NC, Richmond VA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07745504
Phase3, Recruiting
Active & Responsive
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
for
Depressive Disorder, Major
Location: Boston MA, Watertown MA, Foxborough MA, Levis,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07412756
Phase3, Recruiting
Active & Responsive
MISHA Post-Market Clinical Study
for
Osteo Arthritis Knee
Location: Raleigh NC, Charlottesville VA, Portland OR, Sonoma CA
Sponsor: Moximed
Sex: All
Age: 25 - 65
Code: NCT06118892
Recruiting
Active & Responsive
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
for
Plaque Psoriasis
Location: Boston MA, Cromwell CT, Quebec, New York NY, Montreal,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07449702
Phase2, Recruiting
Active & Responsive
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity